These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 16772787

  • 1. Targeted molecular therapy of the PI3K pathway: therapeutic significance of PI3K subunit targeting in colorectal carcinoma.
    Rychahou PG, Jackson LN, Silva SR, Rajaraman S, Evers BM.
    Ann Surg; 2006 Jun; 243(6):833-42; discussion 843-4. PubMed ID: 16772787
    [Abstract] [Full Text] [Related]

  • 2. Targeted RNA interference of PI3K pathway components sensitizes colon cancer cells to TNF-related apoptosis-inducing ligand (TRAIL).
    Rychahou PG, Murillo CA, Evers BM.
    Surgery; 2005 Aug; 138(2):391-7. PubMed ID: 16153452
    [Abstract] [Full Text] [Related]

  • 3. mTOR signaling pathway is a target for the treatment of colorectal cancer.
    Zhang YJ, Dai Q, Sun DF, Xiong H, Tian XQ, Gao FH, Xu MH, Chen GQ, Han ZG, Fang JY.
    Ann Surg Oncol; 2009 Sep; 16(9):2617-28. PubMed ID: 19517193
    [Abstract] [Full Text] [Related]

  • 4. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
    Meng Q, Xia C, Fang J, Rojanasakul Y, Jiang BH.
    Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
    Gray MJ, Van Buren G, Dallas NA, Xia L, Wang X, Yang AD, Somcio RJ, Lin YG, Lim S, Fan F, Mangala LS, Arumugam T, Logsdon CD, Lopez-Berestein G, Sood AK, Ellis LM.
    J Natl Cancer Inst; 2008 Jan 16; 100(2):109-20. PubMed ID: 18182619
    [Abstract] [Full Text] [Related]

  • 8. Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer.
    Johnson SM, Gulhati P, Rampy BA, Han Y, Rychahou PG, Doan HQ, Weiss HL, Evers BM.
    J Am Coll Surg; 2010 May 16; 210(5):767-76, 776-8. PubMed ID: 20421047
    [Abstract] [Full Text] [Related]

  • 9. RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitroand in vivo.
    Zhang X, Deng HX, Zhao X, Su D, Chen XC, Chen LJ, Wei YQ, Zhong Q, Li ZY, He X, Yi T.
    Oncology; 2009 May 16; 77(1):22-32. PubMed ID: 19440000
    [Abstract] [Full Text] [Related]

  • 10. Dual PI3K-BRD4 Inhibitor SF1126 Inhibits Colorectal Cancer Cell Growth in Vitro and in Vivo.
    Qin AC, Li Y, Zhou LN, Xing CG, Lu XS.
    Cell Physiol Biochem; 2019 May 16; 52(4):758-768. PubMed ID: 30933440
    [Abstract] [Full Text] [Related]

  • 11. Inositol hexaphosphate suppresses growth and induces apoptosis in HT-29 colorectal cancer cells in culture: PI3K/Akt pathway as a potential target.
    Liu G, Song Y, Cui L, Wen Z, Lu X.
    Int J Clin Exp Pathol; 2015 May 16; 8(2):1402-10. PubMed ID: 25973024
    [Abstract] [Full Text] [Related]

  • 12. Specific inhibition of p110α subunit of PI3K: putative therapeutic strategy for KRAS mutant colorectal cancers.
    Fernandes MS, Melo S, Velho S, Carneiro P, Carneiro F, Seruca R.
    Oncotarget; 2016 Oct 18; 7(42):68546-68558. PubMed ID: 27602501
    [Abstract] [Full Text] [Related]

  • 13. Augmentation of sodium butyrate-induced apoptosis by phosphatidylinositol 3'-kinase inhibition in the KM20 human colon cancer cell line.
    Wang Q, Li N, Wang X, Kim MM, Evers BM.
    Clin Cancer Res; 2002 Jun 18; 8(6):1940-7. PubMed ID: 12060639
    [Abstract] [Full Text] [Related]

  • 14. Depletion of PI3K p85alpha induces cell cycle arrest and apoptosis in colorectal cancer cells.
    Sun Y, Zhao S, Tian H, Xie X, Xiao F, Li K, Song Y.
    Oncol Rep; 2009 Dec 18; 22(6):1435-41. PubMed ID: 19885597
    [Abstract] [Full Text] [Related]

  • 15. Targeted RNA interference of phosphatidylinositol 3-kinase p110-beta induces apoptosis and proliferation arrest in endometrial carcinoma cells.
    An HJ, Cho NH, Yang HS, Kwak KB, Kim NK, Oh DY, Lee SW, Kim HO, Koh JJ.
    J Pathol; 2007 Jun 18; 212(2):161-9. PubMed ID: 17427168
    [Abstract] [Full Text] [Related]

  • 16. Effects of PTEN on the proliferation and apoptosis of colorectal cancer cells via the phosphoinositol-3-kinase/Akt pathway.
    Sun Y, Tian H, Wang L.
    Oncol Rep; 2015 Apr 18; 33(4):1828-36. PubMed ID: 25683168
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of PI3K p110α contributes to acquired resistance to MET inhibitor, in MET-amplified SNU-5 gastric xenografts.
    Ji F, Liu X, Wu Y, Fang X, Huang G.
    Drug Des Devel Ther; 2015 Apr 18; 9():5697-704. PubMed ID: 26543351
    [Abstract] [Full Text] [Related]

  • 18. Cudraflavone C Induces Tumor-Specific Apoptosis in Colorectal Cancer Cells through Inhibition of the Phosphoinositide 3-Kinase (PI3K)-AKT Pathway.
    Soo HC, Chung FF, Lim KH, Yap VA, Bradshaw TD, Hii LW, Tan SH, See SJ, Tan YF, Leong CO, Mai CW.
    PLoS One; 2017 Apr 18; 12(1):e0170551. PubMed ID: 28107519
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
    Wang Y, Tang Q, Li M, Jiang S, Wang X.
    Biochem Biophys Res Commun; 2014 Feb 07; 444(2):199-204. PubMed ID: 24440701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.